Candice Jones

Candice Jones is an associate in Quinn Emanuel’s Washington, D.C. office.  Candice’s practice focuses on intellectual property litigation.  Her experience includes U.S. district court litigations,  concerning high-stakes, high-technology patent litigation in the areas of biotechnology and pharmaceuticals.

Prior to attending law school, Candice spent more than a decade in the biotechnology arena as a scientist. She began as a post-baccalaureate research fellow at the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). After completing her NIAID fellowship, Candice was awarded a competitive grant from the NIH, National Institute of General Medical Sciences (NIGMS), and conducted research at Johns Hopkins University. Throughout her career, Candice has worked at several notable biopharmaceutical corporations, focusing on researching, developing, and designing novel adenovector-based therapeutics and vaccines, using a gene delivery platform; and designing innovative custom assays, for market, in the fields of molecular biology and genomics. Candice also has an extensive background in high-throughput, cutting-edge, molecular biology techniques, utilizing automation. During her graduate studies, Candice’s thesis work focused on Bacteriophage Mu Derepression and the Effect of SsrA Tagged Repressor Peptides.